tiprankstipranks
Assertio Therapeutics Inc (ASRT)
NASDAQ:ASRT
US Market

Assertio Therapeutics (ASRT) Income Statement

Compare
1,109 Followers

Assertio Therapeutics Income Statement

Last quarter (Q3 2024), Assertio Therapeutics's total revenue was $29.20M, a decrease of -18.03% from the same quarter last year. In Q3, Assertio Therapeutics's net income was $-2.92M. See Assertio Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 152.07M$ 156.23M$ 111.01M$ 106.28M$ 229.50M
Gross Profit
$ 125.05M$ 137.49M$ 95.18M$ 86.40M$ 220.00M
Operating Expenses
$ 368.58M$ 79.39M$ 84.67M$ 133.32M$ 220.75M
Depreciation and Amortization
$ 28.23M$ 33.41M$ 29.11M$ 26.38M$ 102.97M
EBITDA
$ -222.45M$ 72.53M$ 38.78M$ -3.20M$ -61.12M
Operating Income
$ -243.54M$ 57.81M$ 9.42M$ -46.92M$ 3.20M
Other Income/Expenses
$ -10.52M$ -26.65M$ -9.98M$ 36.64M$ -28.06M
Pretax Income
$ -254.05M$ 31.17M$ -553.00K$ -45.51M$ -222.48M
Net Income
$ -331.94M$ 109.63M$ -1.28M$ -28.14M$ -217.20M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -4.67$ 2.33$ -0.03$ -1.07$ -12.29
Diluted EPS
$ -4.67$ 2.01$ -0.03$ -1.07$ -12.29
Weighted Average Shares Outstanding
71.03M 47.00M 43.17M 26.21M 17.68M
Weighted Average Shares Outstanding (Diluted)
71.03M 54.67M 43.17M 26.21M 17.68M
Currency in USD

Assertio Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis